The Kolk lab
Developmental Neurobiology


BRAINCHAIN is a multidisciplinary consortium that aims to establish personalized treatment strategies for patients with Mendelian neurodevelopmental disorders (NDDs), such as Witteveen-Kolk syndrome, Kleefstra syndrome and KBG syndrome. Entirely campus-based, BRAINCHAIN’s team of researchers, clinicians and legislative experts form a Centre of Expertise that generates and integrates knowledge to improve healthcare for patients with Mendelian NDDs.